Retinal degeneration-nanophthalmos-glaucoma syndrome
MONDO:0009978Retinal degeneration-nanophthalmos-glaucoma syndrome is characterized by progressive pigmentary retinal degeneration (with nyctalopia and visual field restriction), cystic macular degeneration and angle closure glaucoma. It has been described in seven members of one family. Patients also have hyperopia and nanophthalmos. The mode of transmission is autosomal recessive.
Also known as: Mackay-Shek-Carr syndrome, MacKay Shek Carr syndrome, retinal degeneration with nanophthalmos, cystic macular degeneration, and angle closure glaucoma, retinal degeneration, nanophthalmos, glaucoma
25 clinical trials for this condition and its sub-types, 0 tagged with Retinal degeneration-nanophthalmos-glaucoma syndrome itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
VR headsets tested as a possible treatment for blindness
Disease control Stopped earlyThis study tested whether using a virtual reality headset for one-hour sessions could help regenerate damaged optic nerves and improve vision in people with glaucoma or other retinal diseases. The idea came from promising results in rodents. However, the trial was terminated earl…
Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Scientists dig into DNA to unravel rare eye disorders
Knowledge-focused Stopped earlyThis study looked at over 100 people with inherited retinal dystrophies, a group of rare eye diseases that can cause vision loss. Researchers collected genetic and eye exam data to find links between specific gene mutations and symptoms. The goal was to better understand these di…
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC